Authors: QUIRT I COUTURE F PICHETTE R OLWENY C WHITE D KING M SAWKA C HUAN S CLINCH J LAU C

Citation: I. Quirt et al., THE ROLE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (EPO) IN REDUCING RED-BLOOD-CELL TRANSFUSIONS AND MAINTAINING QUALITY-OF-LIFE (QOL) IN PATIENTS WITH LYMPHOMA AND SOLID TUMORS RECEIVING CYTOTOXIC CHEMOTHERAPY - RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL-TRIAL, Blood, 88(10), 1996, pp. 1378-1378